文献速递肝病

巨噬细胞-中性粒细胞通过Selplg-Sell-YAP轴驱动NETosis和MASH相关肝纤维化

Macrophage-neutrophil crosstalk via the Selplg-Sell-YAP axis drives NETosis and MASH-associated liver fibrosis.
PubMed 文献 · Hepatology · 2026-06-11

该研究通过单细胞转录组分析发现MASH小鼠肝脏中浸润性Selplg+巨噬细胞扩增,巨噬细胞通过Selplg-Sell轴与中性粒细胞通讯,激活中性粒细胞p38-MST1/2-YAP信号导致NETosis,NETs促进latent TGF-β1激活和HSC活化。药理学阻断sLeX模拟物TBC-1269或YAP抑制可减轻肝炎、NET负荷和纤维化,巨噬细胞系特异性Selplg缺失重现保护效应。

要点

  • 巨噬细胞Selplg与中性粒细胞Sell通过sLeX识别直接接触激活YAP依赖的NETosis
  • NETs作为支架促进整合素依赖的latent TGF-β1激活驱动HSC活化
  • TBC-1269或YAP抑制在预防和治疗设置中均减轻MASH纤维化

核心结论

  • 研究定义了一条连接代谢性炎症与纤维化重构的巨噬细胞-中性粒细胞-HSC信号轴,支持该轴作为MASH相关肝纤维化的治疗靶点。

研究设计与样本

  • 研究对MASH小鼠肝脏进行单细胞转录组分析,并在CDAHFD和WD+CCl4诱导的MASH纤维化模型及人MASLD肝组织中验证。
  • 采用原代细胞共培养系统、结构建模和药理学干预(TBC-1269、YAP抑制)及巨噬细胞系特异性Selplg缺陷小鼠进行机制和功能验证。

主要发现

  • MASH小鼠肝脏中浸润性Selplg+巨噬细胞扩增,巨噬细胞-中性粒细胞通讯通过Selplg-Sell轴增强。
  • 该轴在CDAHFD和WD+CCl4诱导的MASH纤维化模型中持续激活,其细胞组分在人MASLD肝组织中空间富集并与纤维化严重程度相关。
  • 巨噬细胞来源Selplg通过涉及sLeX识别的糖依赖性界面与中性粒细胞Sell结合。
  • Selplg-Sell结合需要直接细胞接触并激活中性粒细胞p38-MST1/2-YAP信号,导致YAP依赖的NET效应程序转录激活。
  • NETs作为细胞外支架促进整合素依赖的latent TGF-β1激活,驱动肝星状细胞活化。

关键数值与推荐

  • 药理学阻断sLeX模拟物TBC-1269或抑制YAP在预防和治疗设置中均减轻肝脏炎症、NET负荷和纤维化。
  • 巨噬细胞系特异性Selplg缺陷重现保护效应,证实巨噬细胞来源Selplg是该致病回路的上游驱动因素。

临床怎么用

  • 靶向巨噬细胞Selplg-Sell轴或YAP介导的NETosis可能成为MASH相关肝纤维化的治疗策略。
  • sLeX模拟物TBC-1269或YAP抑制剂在模型中显示预防和治疗效果,支持进一步临床转化研究。

局限性

  • 研究主要基于小鼠模型和原代细胞共培养系统,人MASLD肝组织数据为关联性观察。
  • 药理学干预和基因缺陷模型的长期安全性和有效性尚未在人体中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatohepatitis (MASH)-associated fibrosis is a pivotal stage toward end-stage liver disease. However, the immune mechanisms orchestrating the transition from inflammation to fibrosis remain elusive. We aimed to dissect the myeloid-cell crosstalk driving this transition and identify therapeutic targets. APPROACH AND RESULTS: Single-cell transcriptomic analysis of MASH mouse livers revealed expansion of infiltrating Selplg + macrophages and enhanced macrophage-neutrophil communication through the Selplg-Sell axis. This axis was consistently activated in CDAHFD- and WD+CCl 4 -induced MASH fibrosis models, and its cellular components were spatially enriched and associated with fibrosis severity in human MASLD liver tissues. Structural modeling showed that macrophage-derived Selplg engaged neutrophil Sell through a glycan-dependent interface involving sialyl-Lewis X (sLeX) recognition. In primary cell co-culture systems, Selplg-Sell engagement required direct cell-cell contact and activated neutrophil p38-MST1/2-YAP signaling, leading to YAP-dependent transcriptional activation of neutrophil extracellular trap (NET) effector programs. NETs subsequently acted as extracellular scaffolds that promoted integrin-dependent activation of latent TGF-β1, thereby driving hepatic stellate cell activation. Pharmacological blockade with the sLeX mimetic TBC-1269 or YAP inhibition attenuated hepatic inflammation, NET burden, and fibrosis under both preventive and therapeutic settings. Macrophage-lineage-specific Selplg deficiency further recapitulated these protective effects, confirming macrophage-derived Selplg as an upstream driver of this pathogenic circuit. CONCLUSIONS: This study defines a macrophage-neutrophil-HSC signaling axis linking metabolic inflammation to fibrotic remodeling in MASH. Macrophage-derived Selplg drives Sell-dependent YAP-mediated NETosis, while NETs further promote latent TGF-β1 activation and HSC activation. These findings support the axis as a therapeutic target for MASH-associated liver fibrosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Nian F, Wu C, Wu D, et al. Macrophage-neutrophil crosstalk via the Selplg-Sell-YAP axis drives NETosis and MASH-associated liver fibrosis. Hepatology. 2026. PMID: 42274998. doi:10.1097/HEP.0000000000001807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。